Search
for
Sort by
Research 211–240 of 595
- The concealed side of caspases: beyond a killer of cells
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics
- Drug eruptions in dermatology
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Induction of hair follicle neogenesis with cultured mouse dermal papilla cells in de novo regenerated skin tissues
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Novel therapies for alopecia areata: The era of rational drug development
- Retinoids and Phototherapy for Psoriasis
- Oxidative stress and alopecia areata
- Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts
- Etiopathogenesis of Alopecia Areata
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Janus Kinase inhibitors in dermatology: a review
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- New therapies for alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- Alopecia Areata and Alopecia Areata Incognita
- Diagnosis and management of hair loss in children
- Mesenchymal stem cell therapy for skin repair and rejuvenation